These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22360268)

  • 1. Network-based analysis of complex diseases.
    Liu ZP; Wang Y; Zhang XS; Chen L
    IET Syst Biol; 2012 Feb; 6(1):22-33. PubMed ID: 22360268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network-based drug repositioning.
    Wu Z; Wang Y; Chen L
    Mol Biosyst; 2013 Jun; 9(6):1268-81. PubMed ID: 23493874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic network modeling and simulation for drug targeting and discovery.
    Kim HU; Sohn SB; Lee SY
    Biotechnol J; 2012 Mar; 7(3):330-42. PubMed ID: 22125297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cancer signaling networks by systems biology to develop therapies.
    Prasasya RD; Tian D; Kreeger PK
    Semin Cancer Biol; 2011 Jun; 21(3):200-6. PubMed ID: 21511035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-based drugs and biomarkers.
    Erler JT; Linding R
    J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of network analyses for elucidating mechanisms in cardiovascular disease.
    Diez D; Wheelock AM; Goto S; Haeggström JZ; Paulsson-Berne G; Hansson GK; Hedin U; Gabrielsen A; Wheelock CE
    Mol Biosyst; 2010 Feb; 6(2):289-304. PubMed ID: 20094647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction networks: from protein functions to drug discovery. A review.
    Chautard E; Thierry-Mieg N; Ricard-Blum S
    Pathol Biol (Paris); 2009 Jun; 57(4):324-33. PubMed ID: 19070972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network systems biology for drug discovery.
    Arrell DK; Terzic A
    Clin Pharmacol Ther; 2010 Jul; 88(1):120-5. PubMed ID: 20520604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
    Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
    J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression complex networks: synthesis, identification, and analysis.
    Lopes FM; Cesar RM; Costa Lda F
    J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding fractal patterns in molecular interaction networks: a case study in Alzheimer's disease.
    Wu X; Huan T; Pandey R; Zhou T; Chen JY
    Int J Comput Biol Drug Des; 2009; 2(4):340-52. PubMed ID: 20090175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems biology impact on antiepileptic drug discovery.
    Margineanu DG
    Epilepsy Res; 2012 Feb; 98(2-3):104-15. PubMed ID: 22055355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.
    Hohman M; Gregory K; Chibale K; Smith PJ; Ekins S; Bunin B
    Drug Discov Today; 2009 Mar; 14(5-6):261-70. PubMed ID: 19231313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the role of network and systems biology in drug discovery.
    Pujol A; Mosca R; Farrés J; Aloy P
    Trends Pharmacol Sci; 2010 Mar; 31(3):115-23. PubMed ID: 20117850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.